December 6, 2007 / 11:38 AM / 10 years ago

BG Medicine cuts estimated IPO price range to $8-$10/shr

Dec 6 (Reuters) - Molecular diagnostics company BG Medicine Inc cut the estimated price range of its initial public offering of 4.5 million shares to $8 to $10 a share, from $14 to $16 per share, according to a regulatory filing.

The Waltham, Massachusetts-based company has applied for a Nasdaq listing under the symbol “BGMD,” it said in a filing with the U.S. Securities and Exchange Commission. (Reporting by Neha Pathania in Bangalore)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below